Molecular fingerprint could predict lung cancer patients who will respond to immunotherapy – The Pharmaceutical Journal
The Pharmaceutical Journal |
Molecular fingerprint could predict lung cancer patients who will respond to immunotherapy
The Pharmaceutical Journal Immunotherapy is becoming an increasingly important cancer therapy, but only around 30% of patients benefit from it. Previous research indicated that the level of cytotoxic T-cell infiltration into the tumour might predict treatment response. In a … |
